OcuMension
Latest round
- Series B
Last raised
- Jun 2019
Total raised
- $200M
Investors
- 8
About OcuMension
Established in 2018 and based in Shanghai, China, OcuMension is a leading platform in ophthalmology dedicated to providing comprehensive treatment solutions for eye diseases. The company has a robust pipeline of 20 ophthalmic drug assets, covering both anterior and posterior segments of the eye. The company's business model primarily involves licensing and commercializing overseas drugs within China. specializes in the development of a diverse range of ophthalmic drugs, with 16 drugs currently in various stages of development. Over 60% of these are acquired through licensing agreements with international pharmaceutical companies, including EyePoint, NicOx SA, Huonland, Senju, and SanBio. The company's product line covers the full spectrum of ophthalmic treatments, aiming to address unmet medical needs in the field of eye care. The company generates revenue through the licensing, development, and commercialization of ophthalmic drugs, providing innovative treatments for a variety of eye conditions.
Who invested in OcuMension
8 investors across 2 rounds
See all investors in OcuMension
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about OcuMension
Who invested in OcuMension?
OcuMension has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has OcuMension raised?
OcuMension has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did OcuMension last raise money?
OcuMension's most recent round on record is a Series B, in Jun 2019.
What does OcuMension do?
Established in 2018 and based in Shanghai, China, OcuMension is a leading platform in ophthalmology dedicated to providing comprehensive treatment solutions for eye diseases.
Where is OcuMension headquartered?
OcuMension is headquartered in Shanghai, China.
Which VCs invest in companies like OcuMension?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at OcuMension's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like OcuMension? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.